anonymous
Guest
anonymous
Guest
Rule #4 disgruntled reps with poor performance make way too many excuses.
Rule #5 unqualified people who pass themselves off as competent businessmen make way too much money.
Rule #4 disgruntled reps with poor performance make way too many excuses.
Rule #5 unqualified people who pass themselves off as competent businessmen make way too much money.
When will this company be de-listed. They are trading at $0.26 per share. One of their board members has the initials RB and owns a lab in PA. He is a fake doctor that can't get licensed in US but still calls himself an MD. What a joke of a company!
++++++++++++++++The company, which has about a dozen employees, generated sales of just under $1.7 million and recorded a net loss of $10.8 million in 2018.
The Thorofare company is selling 1.99 million units — each consisting of one share of common stock and one preferred stock warrant to purchase one share of series C convertible preferred stock — at $4 per unit.
Akers, in documents filed with the Securities and Exchange Commission, said it plans to use the estimated $7.96 million in proceeds from the public stock sale for working capital and other general corporate purposes, which may include funding the "exploration of strategic alternatives." Exploration of strategic alternatives = is it viable and profitable to sell pot on the open market that will eventually get back to kids in elementary schools and playgrounds. Now don't forget to creatively line your pockets with that $7.96 million dollars raised by splicing and dicing the stock before declaring bankruptcy. LOL